Bilharzia & Viral Hepatitis - Imam Waked, MD, FRCP, FAASLD

Conference on Liver Disease in Africa (COLDA) 2023

Compared to the Wild-type, the G1862T Mutant of Hepatitis B Virus (HBV) Induces Upregulation of Fibronectin Expression and Wnt/ β--catenin Pathway in Vitro

Conference on Liver Disease in Africa (COLDA) 2023

Molecular Characterization of Hepatitis B Virus Infection in HIV Infected Adults On Antiretroviral Therapy in Nairobi, Kenya

Conference on Liver Disease in Africa (COLDA) 2023

A New Player in the Management of Liver Disease in Sub-Saharan Africa: The Tanzania IR Experience - Erick Mbuguje, MD

Conference on Liver Disease in Africa (COLDA) 2023

Management of Complications of Cirrhosis - Eva Justine Uiso, MD, MMED, MSc

Conference on Liver Disease in Africa (COLDA) 2023

Introducing Sofosbuvir/Velpatasvir+Ribavirin as a Generic Retreatment Regimen for Hepatitis C: A Prospective Cohort Study in Rwanda

Conference on Liver Disease in Africa (COLDA) 2023

Virological Characterization of Treatment Failures and Retreatment Outcomes in People Living with “Unusual” HCV Genotype 1 Subtypes

Conference on Liver Disease in Africa (COLDA) 2023

HBeAg and HBV DNA in the Hepatitis B in Africa Collaborative Network (HEPSANET)

Conference on Liver Disease in Africa (COLDA) 2023

Effectiveness of Tenofovir Prophylaxis for the Prevention of Mother-To-Child- Transmission of Hepatitis B Virus in Burkina Faso

Conference on Liver Disease in Africa (COLDA) 2023

Evaluation of Interventions to Improve Timely Hepatitis B Birth Dose Vaccination Coverage Among Infants in Nigeria

Conference on Liver Disease in Africa (COLDA) 2023

Sustainable Access to Diagnostics & Therapeutics for HBV - John C. Rwegasha,MBChB, MMED, FRCP (Lond), MSc

Conference on Liver Disease in Africa (COLDA) 2023

HCV: Effect of Reinfection on Elimination - Importance of Self Testing - Janvier Serumondo, MD, MPH, MTM

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis E Virus Detected in Wastewater Samples in South Africa

Conference on Liver Disease in Africa (COLDA) 2023

Time to Initiation of Hepatitis B Treatment Is Reduced with the Use of the Xpert HBV DNA Kit

Conference on Liver Disease in Africa (COLDA) 2023

A Hepatitis B Virus Dual Point-of-Care Test Strategy to Identify Treatment-Eligible Patients in Africa

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis B (HBV) Testing and Treatment Policy Assessment in Six African Countries: Examples to Inform HBV Program Scale-Up

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis B Virus Genotypes - Anna Kramvis, BSc Hons, PhD

Conference on Liver Disease in Africa (COLDA) 2023

Barriers to Implementation/Access to Care - Danjuma K. Adda, MPH, FIMS, Dip-IMS

Conference on Liver Disease in Africa (COLDA) 2023

WHO HBV Guidelines - New Directions for Hepatitis B Treatment and Care and Implications for Africa - Philippa Easterbrook, MD, FRCP, MPH, DTM&H

Conference on Liver Disease in Africa (COLDA) 2023

African CDC - Growing Portfolio of Hepatitis-Related Activities - Hanna Amanuel Tesfahunei, MSc

Conference on Liver Disease in Africa (COLDA) 2023

United Nations Group of Friends to Eliminate Hepatitis - John Ward, MD

Conference on Liver Disease in Africa (COLDA) 2023

Endogeneous Retroviruses and Inflammation - Yasmine Belkaid, PhD

Viral Infections & Inflammation Workshop 2023

Summary Video for Clinicians - Roger Paredes, PhD

Viral Infections & Inflammation Workshop 2023

Determinants of the Onset and Prognosis of the Post-COVID-19 Condition - R. Paredes, MD, PhD.pdf

Viral Infections & Inflammation Workshop 2023